OMNICELL INC (OMCL) Stock Price & Overview
NASDAQ:OMCL • US68213N1090
The current stock price of OMCL is 39.83 USD. Today OMCL is down by -3.56%. In the past month the price increased by 7.45%. In the past year, price increased by 20.7%.
OMCL Key Statistics
- Market Cap
- 1.81B
- P/E
- 24.59
- Fwd P/E
- 22.30
- EPS (TTM)
- 1.62
- Dividend Yield
- N/A
OMCL Stock Performance
OMCL Stock Chart
OMCL Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to OMCL. When comparing the yearly performance of all stocks, OMCL turns out to be only a medium performer in the overall market: it outperformed 55.27% of all stocks.
OMCL Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to OMCL. Both the profitability and the financial health of OMCL get a neutral evaluation. Nothing too spectacular is happening here.
OMCL Earnings
On February 5, 2026 OMCL reported an EPS of 0.4 and a revenue of 313.98M. The company missed EPS expectations (-20.98% surprise) and missed revenue expectations (-1.78% surprise).
OMCL Forecast & Estimates
14 analysts have analysed OMCL and the average price target is 58.58 USD. This implies a price increase of 47.07% is expected in the next year compared to the current price of 39.83.
For the next year, analysts expect an EPS growth of 10.28% and a revenue growth 4.72% for OMCL
OMCL Groups
Sector & Classification
OMCL Financial Highlights
Over the last trailing twelve months OMCL reported a non-GAAP Earnings per Share(EPS) of 1.62. The EPS decreased by -4.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.17% | ||
| ROA | 0.1% | ||
| ROE | 0.17% | ||
| Debt/Equity | 0.14 |
OMCL Ownership
OMCL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.61 | 190.38B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.29 | 174.071B | ||
| SYK | STRYKER CORP | 24.19 | 139.513B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.56 | 105.876B | ||
| IDXX | IDEXX LABORATORIES INC | 41.18 | 48.442B | ||
| BDX | BECTON DICKINSON AND CO | 12.14 | 47.586B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.34 | 47.376B | ||
| RMD | RESMED INC | 20.6 | 36.838B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.63 | 33.849B | ||
| DXCM | DEXCOM INC | 27.04 | 26.209B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11 | 18.413B | ||
| HOLX | HOLOGIC INC | 15.4 | 16.908B | ||
| PODD | INSULET CORP | 37.18 | 16.686B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About OMCL
Company Profile
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,580 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Company Info
OMNICELL INC
4220 North Freeway
Fort Worth TEXAS 94043 US
CEO: Randall A. Lipps
Employees: 3580
Phone: 18774159990
OMNICELL INC / OMCL FAQ
What does OMNICELL INC do?
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. The company is headquartered in Fort Worth, Texas and currently employs 3,580 full-time employees. The company went IPO on 2001-08-08. The firm is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Can you provide the latest stock price for OMNICELL INC?
The current stock price of OMCL is 39.83 USD. The price decreased by -3.56% in the last trading session.
Does OMCL stock pay dividends?
OMCL does not pay a dividend.
How is the ChartMill rating for OMNICELL INC?
OMCL has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is OMNICELL INC (OMCL) stock traded?
OMCL stock is listed on the Nasdaq exchange.
What is the Short Interest ratio of OMNICELL INC (OMCL) stock?
The outstanding short interest for OMNICELL INC (OMCL) is 5.75% of its float.